- Home
- AEE vs PODD Comparison
AEE vs PODD Comparison
Compare AEE & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEE
- PODD
- Stock Information
- Founded
- AEE 1901
- PODD 2000
- Country
- AEE United States
- PODD United States
- Employees
- AEE N/A
- PODD N/A
- Industry
- AEE Power Generation
- PODD Medical/Dental Instruments
- Sector
- AEE Utilities
- PODD Health Care
- Exchange
- AEE Nasdaq
- PODD Nasdaq
- Market Cap
- AEE 27.3B
- PODD 22.1B
- IPO Year
- AEE N/A
- PODD 2007
- Fundamental
- Price
- AEE $101.54
- PODD $318.59
- Analyst Decision
- AEE Buy
- PODD Strong Buy
- Analyst Count
- AEE 12
- PODD 19
- Target Price
- AEE $109.83
- PODD $338.79
- AVG Volume (30 Days)
- AEE 1.6M
- PODD 453.1K
- Earning Date
- AEE 11-05-2025
- PODD 11-06-2025
- Dividend Yield
- AEE 2.80%
- PODD N/A
- EPS Growth
- AEE 2.91
- PODD N/A
- EPS
- AEE 4.55
- PODD 3.32
- Revenue
- AEE $8,119,000,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- AEE $16.34
- PODD $29.27
- Revenue Next Year
- AEE $6.04
- PODD $18.30
- P/E Ratio
- AEE $22.33
- PODD $95.93
- Revenue Growth
- AEE 17.75
- PODD 26.00
- 52 Week Low
- AEE $85.27
- PODD $230.05
- 52 Week High
- AEE $106.73
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- AEE 40.25
- PODD 48.46
- Support Level
- AEE $101.91
- PODD $309.27
- Resistance Level
- AEE $104.94
- PODD $326.81
- Average True Range (ATR)
- AEE 1.45
- PODD 7.21
- MACD
- AEE -0.52
- PODD -0.50
- Stochastic Oscillator
- AEE 21.24
- PODD 35.87
About AEE Ameren Corporation
Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas through the company's two main subsidiaries, Ameren Missouri and Ameren Illinois. It serves 2.5 million electricity customers and approximately 1 million natural gas customers accross its two service territories.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.